Showing results (1001-1010 of 1,020) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|August 10, 2026
Survival of U.S. Military Service Members with Hodgkin Lymphoma by Post 9/11 Deployment StatusSteven Gibson, Sarah Darmon, Wendy Cozen, et al.
Cancer Research Communications|August 10, 2026
Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patientsAnnie Blair Richardson, Payel Chatterjee, Rachele Rosati, et al.
Cancer Research Communications|August 25, 2026
Community-Based Hereditary Breast and Ovarian Cancer Family History Assessment and Genetic Testing among Spanish-Speaking Hispanic/Latina Women in CaliforniaDaisy M Montoya, Amanda F Corpuz, Karla E Gonzalez, et al.
Cancer Research Communications|August 19, 2026
FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancerTorbjørn Amundsen Lien, Sushil Dhakal, Anne Marthe Fosdahl Wium, et al.
Cancer Research Communications|August 21, 2026
Impact of proton versus photon (chemo)radiation on circulating immune cells in head and neck cancerAnneke L Eerkens, Nienke van Rooij, Annechien Plat, et al.
Cancer Research Communications|August 19, 2026
Inhibiting CXCR2 remodels the tumor microenvironment and blunts tumor progression and dissemination of high-grade serous carcinomaRailey G Mikeska, Lily Elizabeth R Feldman, Elizabeth R Woodruff, et al.
Cancer Research Communications|August 28, 2026
Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung CancerUtsav Sen, Dalia Natour, Subhamoy Chakraborty, et al.
Cancer Research Communications|August 27, 2026
The GENIE Data Model: A Solid Tumor, Person-Centric Framework for Scalable, Harmonized Precision Oncology Data CollectionJennifer N Hoppe, Jocelyn Lee, Tomi F Akinyemiju, et al.
Cancer Research Communications|September 3, 2026
Transcriptome-based synthetic lethality predictions to improve targeted therapy/immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECTYewon Kim, Matthew Nagy, Rebecca Pollard, et al.
Cancer Research Communications|September 4, 2026
A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal CancersMarwan Fakih, Toshihiko Doi, Anthony Tolcher, et al.
Pageof 102